Annual Accounts Payable
$3.64 M
-$13.80 M-79.12%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual accounts payable is $3.64 million, with the most recent change of -$13.80 million (-79.12%) on December 31, 2023.
- During the last 3 years, MCRB annual accounts payable has fallen by -$377.00 thousand (-9.38%).
- MCRB annual accounts payable is now -79.12% below its all-time high of $17.44 million, reached on December 31, 2022.
Performance
MCRB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.25 M
+$3.44 M+71.64%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly accounts payable is $8.25 million, with the most recent change of +$3.44 million (+71.64%) on September 30, 2024.
- Over the past year, MCRB quarterly accounts payable has increased by +$4.61 million (+126.70%).
- MCRB quarterly accounts payable is now -52.67% below its all-time high of $17.44 million, reached on December 31, 2022.
Performance
MCRB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MCRB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.1% | +126.7% |
| 3 y3 years | -9.4% | -52.7% |
| 5 y5 years | -43.2% | -52.7% |
MCRB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.1% | at low | -52.7% | +126.7% |
| 5 y | 5-year | -79.1% | at low | -52.7% | +126.7% |
| alltime | all time | -79.1% | +826.5% | -52.7% | +644.3% |
Seres Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.25 M(+71.6%) |
| Jun 2024 | - | $4.81 M(-7.9%) |
| Mar 2024 | - | $5.22 M(+43.3%) |
| Dec 2023 | $3.64 M(-79.1%) | $3.64 M(-59.4%) |
| Sep 2023 | - | $8.96 M(-30.7%) |
| Jun 2023 | - | $12.92 M(+5.1%) |
| Mar 2023 | - | $12.30 M(-29.5%) |
| Dec 2022 | $17.44 M(+27.0%) | $17.44 M(+66.9%) |
| Sep 2022 | - | $10.45 M(-25.3%) |
| Jun 2022 | - | $13.99 M(+106.0%) |
| Mar 2022 | - | $6.79 M(-50.6%) |
| Dec 2021 | $13.73 M(+241.8%) | $13.73 M(+59.3%) |
| Sep 2021 | - | $8.62 M(+58.2%) |
| Jun 2021 | - | $5.45 M(+11.7%) |
| Mar 2021 | - | $4.88 M(+21.4%) |
| Dec 2020 | $4.02 M(-17.3%) | $4.02 M(-35.2%) |
| Sep 2020 | - | $6.20 M(+49.0%) |
| Jun 2020 | - | $4.16 M(-24.6%) |
| Mar 2020 | - | $5.52 M(+13.6%) |
| Dec 2019 | $4.86 M | $4.86 M(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $4.46 M(-6.5%) |
| Jun 2019 | - | $4.76 M(+21.6%) |
| Mar 2019 | - | $3.92 M(-38.9%) |
| Dec 2018 | $6.42 M(-8.8%) | $6.42 M(-0.9%) |
| Sep 2018 | - | $6.47 M(+25.5%) |
| Jun 2018 | - | $5.16 M(-4.8%) |
| Mar 2018 | - | $5.42 M(-23.0%) |
| Dec 2017 | $7.03 M(-7.3%) | $7.03 M(+30.7%) |
| Sep 2017 | - | $5.38 M(+38.3%) |
| Jun 2017 | - | $3.89 M(-31.0%) |
| Mar 2017 | - | $5.64 M(-25.7%) |
| Dec 2016 | $7.59 M(+40.6%) | $7.59 M(+79.4%) |
| Sep 2016 | - | $4.23 M(-5.1%) |
| Jun 2016 | - | $4.45 M(-22.7%) |
| Mar 2016 | - | $5.76 M(+6.8%) |
| Dec 2015 | $5.40 M(+149.2%) | $5.40 M(+158.4%) |
| Sep 2015 | - | $2.09 M(+23.8%) |
| Jun 2015 | - | $1.69 M(+52.2%) |
| Mar 2015 | - | $1.11 M(-48.8%) |
| Dec 2014 | $2.17 M(+451.1%) | $2.17 M |
| Dec 2013 | $393.00 K | - |
FAQ
- What is Seres Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Seres Therapeutics?
- What is Seres Therapeutics annual accounts payable year-on-year change?
- What is Seres Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Seres Therapeutics?
- What is Seres Therapeutics quarterly accounts payable year-on-year change?
What is Seres Therapeutics annual accounts payable?
The current annual accounts payable of MCRB is $3.64 M
What is the all time high annual accounts payable for Seres Therapeutics?
Seres Therapeutics all-time high annual accounts payable is $17.44 M
What is Seres Therapeutics annual accounts payable year-on-year change?
Over the past year, MCRB annual accounts payable has changed by -$13.80 M (-79.12%)
What is Seres Therapeutics quarterly accounts payable?
The current quarterly accounts payable of MCRB is $8.25 M
What is the all time high quarterly accounts payable for Seres Therapeutics?
Seres Therapeutics all-time high quarterly accounts payable is $17.44 M
What is Seres Therapeutics quarterly accounts payable year-on-year change?
Over the past year, MCRB quarterly accounts payable has changed by +$4.61 M (+126.70%)